{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:24:10Z","timestamp":1790389450648,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"11-12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.2119\/molmed.2011.00149","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T17:46:12Z","timestamp":1322934372000},"page":"1285-1294","source":"Crossref","is-referenced-by-count":70,"title":["Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Eleonora","family":"Patsenker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunda","family":"Millonig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Agaimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Wissniowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vreni","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Brenneisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut K.","family":"Seitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Stickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,19]]},"reference":[{"key":"17111285_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. (2005) Liver fibrosis. J. Clin. Invest. 115:209\u201318.","journal-title":"J. Clin. Invest."},{"key":"17111285_CR2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/s-2001-17558","volume":"21","author":"R Bataller","year":"2001","unstructured":"Bataller R, Brenner DA. (2001) Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 21:437\u201351.","journal-title":"Semin. Liver Dis."},{"issue":"Suppl 1","key":"17111285_CR3","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1111\/j.1440-1746.2006.04659.x","volume":"22","author":"CJ Parsons","year":"2007","unstructured":"Parsons CJ, Takashima M, Rippe RA. (2007) Molecular mechanisms of hepatic fibrogenesis. J. Gastroenterol. Hepatol. 22 Suppl 1:S79\u201384.","journal-title":"J. Gastroenterol. Hepatol."},{"key":"17111285_CR4","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology. 134:1655\u201369.","journal-title":"Gastroenterology"},{"key":"17111285_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1517\/14728222.11.3.403","volume":"11","author":"A Mallat","year":"2007","unstructured":"Mallat A, Teixeira-Clerc F, Deveaux V, Lotersztajn S. (2007) Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases. Expert Opin. Ther. Targets 11:403\u20139.","journal-title":"Expert Opin. Ther. Targets"},{"issue":"Suppl1","key":"17111285_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2826.2008.01679.x","volume":"20","author":"P Caraceni","year":"2008","unstructured":"Caraceni P, Domenicali M, Bernardi M. (2008) The endocannabinoid system and liver diseases. J. Neuroendocrinol. 20Suppl 1:47\u201352.","journal-title":"J. Neuroendocrinol."},{"key":"17111285_CR7","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.3748\/wjg.14.6109","volume":"14","author":"A Parfieniuk","year":"2008","unstructured":"Parfieniuk A, Flisiak R. (2008) Role of cannabinoids in chronic liver diseases. World J. Gastroenterol. 14:6109\u201314.","journal-title":"World J. Gastroenterol."},{"key":"17111285_CR8","doi-asserted-by":"publisher","first-page":"G357","DOI":"10.1152\/ajpgi.00456.2007","volume":"294","author":"SV Siegmund","year":"2008","unstructured":"Siegmund SV, Schwabe RF. (2008) Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 294:G357\u201362.","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"17111285_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nm1421","volume":"12","author":"F Teixeira-Clerc","year":"2006","unstructured":"Teixeira-Clerc F, et al. (2006) CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat. Med. 12:671\u20136.","journal-title":"Nat. Med."},{"key":"17111285_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1053\/j.gastro.2004.12.050","volume":"128","author":"B Julien","year":"2005","unstructured":"Julien B, et al. (2005) Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology. 128:742\u201355.","journal-title":"Gastroenterology"},{"key":"17111285_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cgh.2007.10.021","volume":"6","author":"JH Ishida","year":"2008","unstructured":"Ishida JH, et al. (2008) Influence of cannabis use on severity of hepatitis C disease. Clin. Gastroenterol. Hepatol. 6:69\u201375.","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"17111285_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/hep.20733","volume":"42","author":"C Hezode","year":"2005","unstructured":"Hezode C, et al. (2005) Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology. 42:63\u201371.","journal-title":"Hepatology"},{"key":"17111285_CR13","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1053\/j.gastro.2007.11.039","volume":"134","author":"C Hezode","year":"2008","unstructured":"Hezode C, et al. (2008) Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Gastroenterology. 134:432\u20139.","journal-title":"Gastroenterology"},{"key":"17111285_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/j.1478-3231.2009.02137.x","volume":"30","author":"P Caraceni","year":"2009","unstructured":"Caraceni P, et al. (2009) Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis. Liver Int. 30:816\u201325.","journal-title":"Liver Int."},{"key":"17111285_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1053\/jhep.2003.50459","volume":"38","author":"KK Biswas","year":"2003","unstructured":"Biswas KK, et al. (2003) Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis. Hepatology. 38:1167\u201377.","journal-title":"Hepatology"},{"key":"17111285_CR16","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI200523057","volume":"115","author":"D Osei-Hyiaman","year":"2005","unstructured":"Osei-Hyiaman D, et al. (2005) Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 115:1298\u2013305.","journal-title":"J. Clin. Invest."},{"key":"17111285_CR17","doi-asserted-by":"publisher","first-page":"10431","DOI":"10.1074\/jbc.M509706200","volume":"281","author":"SV Siegmund","year":"2006","unstructured":"Siegmund SV, et al. (2006) Fatty acid amide hydrolase determines anandamide-induced cell death in the liver. J. Biol. Chem. 281:10431\u20138.","journal-title":"J. Biol. Chem."},{"key":"17111285_CR18","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/sj.cdd.4401284","volume":"10","author":"M Maccarrone","year":"2003","unstructured":"Maccarrone M, Finazzi-Agro A. (2003) The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ. 10:946\u201355.","journal-title":"Cell Death Differ."},{"key":"17111285_CR19","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/hep.20667","volume":"41","author":"SV Siegmund","year":"2005","unstructured":"Siegmund SV, Uchinami H, Osawa Y, Brenner DA, Schwabe RF. (2005) Anandamide induces necrosis in primary hepatic stellate cells. Hepatology. 41:1085\u201395.","journal-title":"Hepatology"},{"key":"17111285_CR20","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1096\/fj.06-7717com","volume":"21","author":"SV Siegmund","year":"2007","unstructured":"Siegmund SV, et al. (2007) The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J. 21:2798\u2013806.","journal-title":"FASEB J."},{"key":"17111285_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cmet.2007.12.007","volume":"7","author":"WI Jeong","year":"2008","unstructured":"Jeong WI, et al. (2008) Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab. 7:227\u201335.","journal-title":"Cell Metab."},{"key":"17111285_CR22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/j.1478-3231.2011.02496.x","volume":"31","author":"J Trebicka","year":"2011","unstructured":"Trebicka J, et al. (2011) Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Liver Int. 31:860\u201370.","journal-title":"Liver Int."},{"issue":"4","key":"17111285_CR23","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/hep.24524","volume":"54","author":"Alexandre Louvet","year":"2011","unstructured":"Louvet A, et al. (2011) Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating kupffer cell polarization in mice. Hepatology. doi: 10.1002\/hep.24524. [Epub ahead of print].","journal-title":"Hepatology"},{"key":"17111285_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000090165","volume":"23","author":"SV Siegmund","year":"2005","unstructured":"Siegmund SV, Haas S, Singer MV (2005) Animal models and their results in gastrointestinal alcohol research. Dig. Dis. 23:181\u201394.","journal-title":"Dig. Dis."},{"key":"17111285_CR25","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 41:1313\u201321.","journal-title":"Hepatology"},{"key":"17111285_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jhep.2006.03.017","volume":"45","author":"M Kornek","year":"2006","unstructured":"Kornek M, et al. (2006) Combination of systemic thioacetamide (TAA) injections and ethanol feeding accelerates hepatic fibrosis in C3H\/He mice and is associated with intrahepatic up regulation of MMP-2, VEGF and ICAM-1. J. Hepatol. 45:370\u20136.","journal-title":"J. Hepatol."},{"key":"17111285_CR27","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2008.04.009","volume":"135","author":"E Patsenker","year":"2008","unstructured":"Patsenker E, et al. (2008) Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression. Gastroenterology. 135:660\u201370.","journal-title":"Gastroenterology"},{"key":"17111285_CR28","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/hep.23144","volume":"50","author":"E Patsenker","year":"2009","unstructured":"Patsenker E, et al. (2009) Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis. Hepatology. 50:1501\u201311.","journal-title":"Hepatology"},{"key":"17111285_CR29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.jhep.2006.11.011","volume":"46","author":"E Patsenker","year":"2007","unstructured":"Patsenker E, Popov Y, Wiesner M, Goodman SL, Schuppan D. (2007) Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. J. Hepatol. 46:878\u201387.","journal-title":"J. Hepatol."},{"key":"17111285_CR30","first-page":"C1133","volume":"269","author":"P Failli","year":"1995","unstructured":"Failli P, et al. (1995) The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx. Am. J. Physiol. 269: C1133\u20139.","journal-title":"J. Physiol."},{"key":"17111285_CR31","first-page":"573","volume":"22","author":"Y Inagaki","year":"1995","unstructured":"Inagaki Y, et al. (1995) Regulation of the alpha 2(I) collagen gene transcription in fat-storing cells derived from a cirrhotic liver. Hepatology. 22:573\u20139.","journal-title":"Hepatology"},{"key":"17111285_CR32","first-page":"1508","volume":"146","author":"M Rojkind","year":"1995","unstructured":"Rojkind M, et al. (1995) Characterization and functional studies on rat liver fat-storing cell line and freshly isolated hepatocyte coculture system. Am. J. Pathol. 146:1508\u201320.","journal-title":"J. Pathol."},{"key":"17111285_CR33","doi-asserted-by":"publisher","first-page":"G850","DOI":"10.1152\/ajpgi.00523.2007","volume":"294","author":"P Pacher","year":"2008","unstructured":"Pacher P, Gao B. (2008) Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases. Am. J. Physiol. Gastrointest. Liver Physiol. 294:G850\u20134.","journal-title":"Physiol. Gastrointest. Liver Physiol."},{"key":"17111285_CR34","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1055\/s-2001-17552","volume":"21","author":"RC Benyon","year":"2001","unstructured":"Benyon RC, Arthur MJ. (2001) Extracellular matrix degradation and the role of hepatic stellate cells. Semin. Liver Dis. 21:373\u201384.","journal-title":"Semin. Liver Dis."},{"key":"17111285_CR35","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.4049\/jimmunol.178.8.5288","volume":"178","author":"JA Fallowfield","year":"2007","unstructured":"Fallowfield JA, et al. (2007) Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 178:5288\u201395.","journal-title":"J. Immunol."},{"key":"17111285_CR36","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/hep.1840220142","volume":"22","author":"PJ Winwood","year":"1995","unstructured":"Winwood PJ, et al. (1995) Kupffer cell-derived 95-kd type IV collagenase\/gelatinase B: characterization and expression in cultured cells. Hepatology. 22:304\u201315.","journal-title":"Hepatology"},{"issue":"3","key":"17111285_CR37","doi-asserted-by":"publisher","first-page":"G323","DOI":"10.1152\/ajpgi.00394.2009","volume":"298","author":"Yury Popov","year":"2010","unstructured":"Popov Y, et al. Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 298:G323-34.","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"key":"17111285_CR38","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1172\/JCI200112373","volume":"108","author":"E Olaso","year":"2001","unstructured":"Olaso E, et al. (2001) DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. J. Clin. Invest. 108:1369\u201378.","journal-title":"J. Clin. Invest."},{"key":"17111285_CR39","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","volume":"43","author":"Y Popov","year":"2005","unstructured":"Popov Y, Patsenker E, Fickert P, Trauner M, Schuppan D. (2005) Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J. Hepatol. 43:1045\u201354.","journal-title":"J. Hepatol."},{"key":"17111285_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1189\/jlb.0303101","volume":"74","author":"TW Klein","year":"2003","unstructured":"Klein TW, et al. (2003) The cannabinoid system and immune modulation. J. Leukoc. Biol. 74:486\u201396.","journal-title":"J. Leukoc. Biol."},{"key":"17111285_CR41","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/hep.21641","volume":"46","author":"M Gary-Bobo","year":"2007","unstructured":"Gary-Bobo M, et al. (2007) Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa\/fa rats. Hepatology. 46:122\u20139.","journal-title":"Hepatology"},{"key":"17111285_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/biof.5520340202","volume":"34","author":"YH Chen","year":"2008","unstructured":"Chen YH, Wang MF, Liao JW, Chang SP, Hu ML. (2008) Beneficial effects of nicotinamide on alcohol-induced liver injury in senescence-accelerated mice. Biofactors. 34:97\u2013107.","journal-title":"Biofactors"},{"key":"17111285_CR43","doi-asserted-by":"crossref","first-page":"17690","DOI":"10.1016\/S0021-9258(18)45434-8","volume":"262","author":"DA Brenner","year":"1987","unstructured":"Brenner DA, Chojkier M. (1987) Acetaldehyde increases collagen gene transcription in cultured human fibroblasts. J. Biol. Chem. 262:17690\u20135.","journal-title":"J. Biol. Chem."},{"key":"17111285_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0006-2952(77)90310-0","volume":"26","author":"CJ Eriksson","year":"1977","unstructured":"Eriksson CJ, Sippel HW. (1977) The distribution and metabolism of acetaldehyde in rats during ethanol oxidation-I. The distribution of acetaldehyde in liver, brain, blood and breath. Biochem. Pharmacol. 26:241\u20137.","journal-title":"Biochem. Pharmacol."},{"key":"17111285_CR45","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1042\/bj20020949","volume":"368","author":"A Chen","year":"2002","unstructured":"Chen A. (2002) Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells. Biochem. J. 368:683\u201393.","journal-title":"Biochem. J."},{"key":"17111285_CR46","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000090174","volume":"23","author":"SV Siegmund","year":"2005","unstructured":"Siegmund SV, Dooley S, Brenner DA. (2005) Molecular mechanisms of alcohol-induced hepatic fibrosis. Dig. Dis. 23:264\u201374.","journal-title":"Dig. Dis."},{"key":"17111285_CR47","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/JCP.0b013e318172b8bc","volume":"28","author":"M Soyka","year":"2008","unstructured":"Soyka M, et al. (2008) Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial. J. Clin. Psychopharmacol. 28:317\u201324.","journal-title":"J. Clin. Psychopharmacol."},{"key":"17111285_CR48","unstructured":"European Medicines Agency. (2008) The European Medicines Agency recommends suspension of the marketing authorisation of Acomplia [press release]. [cited 2011 Oct 28]. Available from: https:\/\/doi.org\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2009\/11\/news_detail_000244.jsp&murl=menus\/news_and_events\/news_and_events.jsp&mid=WC0b01ac058004d5c1&jsenabled=true"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.crossref.org\/molmed.2011.00149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2119\/molmed.2011.00149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:21:29Z","timestamp":1741983689000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.2119\/molmed.2011.00149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,19]]},"references-count":48,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["17111285"],"URL":"https:\/\/doi.org\/10.2119\/molmed.2011.00149","relation":{},"ISSN":["1076-1551","1528-3658"],"issn-type":[{"value":"1076-1551","type":"print"},{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,19]]}}}